BIOMAT Database Logo BIOMAT Database Logo

Characteristic patterns of Tl-201 chloride and Tc-99m MIBI uptake in a pineocytoma. 1998

K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Department of Neurosurgery, Miyazaki Medical College, Japan. akatoyik@post.miyazaki-med.ac.jp

UI MeSH Term Description Entries
D008297 Male Males
D010870 Pineal Gland A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES. Epiphysis Cerebri,Pineal Body,Corpus Pineale,Gland, Pineal,Pineal Bodies,Pineal Glands
D010871 Pinealoma Neoplasms which originate from pineal parenchymal cells that tend to enlarge the gland and be locally invasive. The two major forms are pineocytoma and the more malignant pineoblastoma. Pineocytomas have moderate cellularity and tend to form rosette patterns. Pineoblastomas are highly cellular tumors containing small, poorly differentiated cells. These tumors occasionally seed the neuroaxis or cause obstructive HYDROCEPHALUS or Parinaud's syndrome. GERMINOMA; CARCINOMA, EMBRYONAL; GLIOMA; and other neoplasms may arise in the pineal region with germinoma being the most common pineal region tumor. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, p2064; Adams et al., Principles of Neurology, 6th ed, p670) Neoplasms, Pineal,Pineal Neoplasms,Pinealocytoma,Pineoblastoma,Pineocytoma,Mixed Pineocytoma-Pineoblastoma,Pineal Gland Tumor,Pineal Parenchymal Tumors,Pineal Tumors,Mixed Pineocytoma Pineoblastoma,Mixed Pineocytoma-Pineoblastomas,Neoplasm, Pineal,Pineal Gland Tumors,Pineal Neoplasm,Pineal Parenchymal Tumor,Pineal Tumor,Pinealocytomas,Pinealomas,Pineoblastomas,Pineocytoma-Pineoblastoma, Mixed,Pineocytoma-Pineoblastomas, Mixed,Pineocytomas,Tumor, Pineal,Tumor, Pineal Gland,Tumor, Pineal Parenchymal,Tumors, Pineal,Tumors, Pineal Gland,Tumors, Pineal Parenchymal
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013793 Thallium A heavy, bluish white metal, atomic number 81, atomic weight [204.382; 204.385], symbol Tl. Thallium-205,Thallium 205
D013794 Thallium Radioisotopes Unstable isotopes of thallium that decay or disintegrate emitting radiation. Tl atoms with atomic weights 198-202, 204, and 206-210 are thallium radioisotopes. Radioisotopes, Thallium
D015899 Tomography, Emission-Computed, Single-Photon A method of computed tomography that uses radionuclides which emit a single photon of a given energy. The camera is rotated 180 or 360 degrees around the patient to capture images at multiple positions along the arc. The computer is then used to reconstruct the transaxial, sagittal, and coronal images from the 3-dimensional distribution of radionuclides in the organ. The advantages of SPECT are that it can be used to observe biochemical and physiological processes as well as size and volume of the organ. The disadvantage is that, unlike positron-emission tomography where the positron-electron annihilation results in the emission of 2 photons at 180 degrees from each other, SPECT requires physical collimation to line up the photons, which results in the loss of many available photons and hence degrades the image. CAT Scan, Single-Photon Emission,CT Scan, Single-Photon Emission,Radionuclide Tomography, Single-Photon Emission-Computed,SPECT,Single-Photon Emission-Computed Tomography,Tomography, Single-Photon, Emission-Computed,Single-Photon Emission CT Scan,Single-Photon Emission Computer-Assisted Tomography,Single-Photon Emission Computerized Tomography,CAT Scan, Single Photon Emission,CT Scan, Single Photon Emission,Emission-Computed Tomography, Single-Photon,Radionuclide Tomography, Single Photon Emission Computed,Single Photon Emission CT Scan,Single Photon Emission Computed Tomography,Single Photon Emission Computer Assisted Tomography,Single Photon Emission Computerized Tomography,Tomography, Single-Photon Emission-Computed
D016708 Synaptophysin A MARVEL domain-containing protein found in the presynaptic vesicles of NEURONS and NEUROENDOCRINE CELLS. It is commonly used as an immunocytochemical marker for neuroendocrine differentiation. p38 Membrane Protein, Synaptic Vesicle

Related Publications

K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Comparison of Tc-99m MIBI and Tl-201 uptake in musculoskeletal lesions.
February 1996, Clinical nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Medullary thyroid carcinoma imaged by Tc-99m MIBI SPECT and Tl-201 chloride/Tc-99m pertechnetate subtraction SPECT.
March 1996, Clinical nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Discordant uptake of Tl-201 and Tc-99m MIBI in a patient with follicular adenoma.
April 2000, Annals of nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Lobar extent of pulmonary lymphangitic carcinomatosis. Tl-201 chloride and Tc-99m MIBI scintigraphic findings.
September 1996, Clinical nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Tc-99m HMPAO and Tl-201 uptake patterns in a malignant undifferentiated orbital neoplasm.
July 2001, Clinical nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Tc-99m MIBI and TI-201 uptake in a benign thymoma.
August 1995, Clinical nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Tl-201, Tc-99m sestamibi, and Tc-99m HMDP uptake in multiple brown tumors.
July 2003, Clinical nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Tl-201 chloride and Tc-99m MIBI accumulation in lung adenocarcinoma in patients with and without distant metastases.
September 2001, Clinical nuclear medicine,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Myocardial scintigraphy using 99m-Tc-methoxyisobutylisonitrile (Tc-MIBI): Is it equivalent to 201-Tl?.
December 1991, Casopis lekaru ceskych,
K Yokogami, and H Kawano, and S Uchinokura, and T Moriyama, and H Uehara, and T Sameshima, and T Goya, and S Wakisaka, and K Nabeshima, and S Nagamachi, and S Jinnouchi
Tc-99m uptake in a parathyroid adenoma. Potential pitfall in Tc-99m/Tl-201 subtraction imaging.
July 1992, Clinical nuclear medicine,
Copied contents to your clipboard!